Monthly Archives: November 2010

IRDA’s clean chit to LIC but no to intra-account transfers

The Insurance Regulatory and Development Authority (IRDA) gave a clean chit to Life Insurance Corporation of India (LIC) after it launched a probe to ascertain whether it has violated rules to transfer profits between its various schemes to make good the deficit in some of its funds.

IRDA Chairman Hari Narayan, on Friday said that the company’s Rs 4,000-crore deficit in three plans of its guaranteed-return annuity polices is not a real cash shortage, but an actuarial shortage. Narayan clarified this after conducting a thorough probe into the books of LIC for the financial year 2009-10.

However, the regulatory body after the probe said that it will not permit transfers by the LIC from one account to another. The three schemes — Jeevan Dhara, Jeevan Suraksha and Jeevan Akshay — were launched in the 1980s and 1990s with assured returns of 11-12%. The actual yields were, however, much less than what investors have been earning due to a drop in interest rates.

Narayan, responding to the queries in the context of reports of LIC incurring a valuation deficit in some of its policies added that there was no need for anxiety. He said in the case of LIC, there seems to be shortage between the assets and the liabilities. “The actual cash disparity could be Rs 300-400 crore a year. LIC generates a lot of surplus. This belongs to the shareholder. This is now used for shortfall”, said Narayan.

The regulator also said these figures were disclosed in LIC’s annual accounts and that they were part of the public sector insurer’s non-performing assets, which were 0.72 per cent of its total assets and the 1.3 million customers of the three plans will not be affected. They are not looking at changes in guidelines but will not permit transfers from one account to another.

LIC, fully-owned by the government, has an asset base of Rs 12 trillion. However, the problems now being encountered by the life insurer only reflect the grave risks associated with assured-return schemes.

LIC officials also said the valuation deficit has been provided for on a year-on-year basis at the time of actuarial valuations, and that LIC has an overall solvency margin currently at Rs 46,000 crore.

LIC’s net profit went up by 11% to Rs 23,478 crore in 2009-10, against Rs 21,152 crore in the previous fiscal. The corporation holds shares valued at over Rs 3.75 lakh crore in over 1,000 companies.

Canara HSBC OBC Life enters group insurance

The three way insurance joint venture Canara HSBC Oriental Bank of Commerce Life Insurance announced its entry into the group insurance business. The venture has a presence in individual life insurance business. The insurer is hoping to get a larger segment of customers by targeting the corporate segment through the three partner banks.

The venture focusing on employee benefit has launched a Group Traditional Plan that offers employee retirement benefits, namely gratuity, superannuation/pension, leave encashment. The company is planning to launch a complete suite of products on the platform in the coming months, including a unit-linked option and group term insurance.

Medical insurance may cover Ayurveda, Unani, Siddha

The General Insurance council formed a three-member committee to study the scope of covering non-allopathic treatment. The council has been approached by the department of Ayush to look into the possibilities of covering claims for non-allopathic treatment.

The committee formed comprises CEOs from Apollo Munich, Star Health and Max Bupa. The committee will examine the details and analyze the advantages disadvantages if the proposal can be accepted or not. The department of Ayush made a presentation before the council arguing that allopathic treatment is costly and many people in rural go for alternative treatment. The committee will give it recommendation to the council and then IRDA will take the final call.

Presently there is one product from Iffco Tokio, Swasthya Kavach, which covers ayurvedic treatment.

We think more products can be designed to cover the alternative treatment but the experience data is not readily available in the usable form and also there is no proper system to establish the proof of treatment. We believe that this kind of product if made cannot be clubbed with the one covering allopathic treatment. Allopathic treatment is costly and so the premium. There is natural disadvantage of paying premium for costlier treatment and going for the cheaper one. A separate product can undertake this issue but then the admin cost and distribution cost should also be tackled properly to make the product viable.

Liberty Mutual to partner Videocon for General Insurance Business

Liberty Mutual of US in association with Videocon Industries of India is planning to tap general insurance business in India. They have announced their joint venture and will apply for license with the regulator by the year end.

In the venture Liberty Mutual will hold 26% of stake with the option to increase it to 49% if the FDI norms changes in the favor. The remaining 74% stake will be held by Videocon.

The two companies in the venture will invest Rs. 300 crore as an initial investment. The company is hopeful to start operations by September next year.

Focusing mainly on the personal line products like motor, home, health and personal accidents, the venture will offer product across segments.